Klippel-Trenaunay-Weber Syndrome

This is a birth defect affecting the legs. It involves abnormal blood vessels (capillaries and veins) and overgrown bones or soft tissue. This can cause swelling, varicose veins, and sometimes tumors (hemangiomas). It's caused by a gene mutation.

Condition

What people with Klippel-Trenaunay-Weber Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Compression therapy for Klippel-Trenaunay-Weber Syndrome?

NameHow it went

About Klippel-Trenaunay-Weber Syndrome

What It Is

Klippel-Trenaunay syndrome (KTS) is a rare condition, present from birth, in which blood vessels, soft tissue and bone in part of the body develop abnormally. It usually affects one leg, less often an arm and rarely the torso. It has three hallmark features: a flat pink-to-maroon birthmark called a port-wine stain, abnormal veins (often large varicose veins on the outer thigh and calf, and sometimes malformed deep veins), and overgrowth that can make the limb larger or longer than the other side. Many people also have abnormal lymphatic vessels, the channels that drain fluid from tissues, which adds swelling. These features cause pain, heaviness, swelling and sometimes difficulty walking. The abnormal veins matter most for health, because slow-moving blood in them can clot. The name Klippel-Trenaunay-Weber is older and can be misleading. It merges KTS with Parkes Weber syndrome, a different disorder in which an enlarged limb has many fast-flowing connections between arteries and veins. KTS is a slow-flow condition, and the two are diagnosed, inherited and treated differently, so it is worth knowing which one has actually been diagnosed.

Causes & Risk Factors

KTS is caused by a change in a gene called PIK3CA, which helps control how cells grow and divide. The change makes this growth signal stay switched on, so the affected tissues, including blood vessels, fat and bone, grow excessively. Not every person with KTS has a detectable PIK3CA change, so other genes may also be involved. The gene change is not inherited. It arises by chance in a single cell early in development before birth, so only the cells descended from it carry the change. This patchy pattern, called mosaicism, explains why the condition affects one region of the body. Nothing a parent did during pregnancy causes it, and people with KTS do not pass it to their children. Parkes Weber syndrome, by contrast, can be inherited, which is one reason telling the two apart matters.

How It's Diagnosed

KTS is diagnosed mainly from the physical findings: the birthmark, the abnormal veins and the size difference of the limb, which are often visible at or soon after birth. Imaging then maps the malformations. Ultrasound with Doppler shows how blood flows through the veins and checks the deep veins; magnetic resonance imaging (MRI) shows how far the abnormal vessels, lymphatic tissue and fat extend, including into the pelvis or abdomen. Confirming slow flow is what separates KTS from Parkes Weber syndrome. Genetic testing can look for a PIK3CA change, usually in a sample of affected tissue rather than blood, because the change is not present in every cell. A negative result does not rule KTS out. Doctors may also check a blood test called D-dimer, a marker of ongoing clotting; a raised level in someone with extensive abnormal veins can signal low-grade clotting within the malformation, which affects planning for surgery and other procedures.

Treatment Options

There is no single cure, so treatment targets the problems each person has, ideally through a vascular anomalies team that brings together dermatology, interventional radiology, orthopedics, surgery and hematology. Compression garments are the everyday foundation. Fitted elastic stockings or sleeves ease aching and swelling from distended veins and lymphatic fluid, though they need to be worn consistently to help. Leg elevation and skin care support them. Troublesome veins and lymphatic pockets can be closed with sclerotherapy (injecting a solution that scars the vessel shut) or with laser or other catheter-based treatment. Laser can lighten the birthmark or treat small blisters on it that leak fluid or bleed. These treatments often need repeating, and surgery to remove abnormal veins or excess tissue is reserved for selected cases because results are limited when the malformation runs deep into the muscle. For a leg that is growing longer, a shoe lift helps prevent a compensating curve of the spine (scoliosis), and a surgery that slows growth at the knee growth plate (epiphysiodesis) can even out leg length in a growing child when timed well. Because blood clots are a real risk, people with extensive abnormal veins are often given a blood thinner, usually heparin injections, before and after procedures, sometimes continuing on a blood-thinning pill. For more severe or progressive disease, medicines that block the overactive growth signal are an option. Sirolimus, an immune-modulating drug used off-label for this purpose, has shrunk slow-flow malformations and improved quality of life in many treated patients; it needs blood level monitoring and can cause mouth sores, raised cholesterol and more infections. Alpelisib (Vijoice) is approved in the US for adults and children 2 and older with severe disease in the PIK3CA-related overgrowth spectrum who need whole-body treatment. Its approval is based on how often lesions shrank, with longer-term benefit still being confirmed, and it can raise blood sugar significantly, so glucose is monitored. Neither medicine corrects bone overgrowth or leg length difference.

What to Expect

KTS is lifelong, and its severity ranges widely. Some people have a birthmark and modest enlargement that rarely limit them; others have a very large limb, pelvic involvement and repeated procedures. Varicose veins often become more prominent through childhood, and limb length differences matter most during growth, which is why children are followed by an orthopedic specialist until they stop growing. Day to day, many people manage aching, heaviness and swelling with compression, activity pacing and comfortable footwear, sometimes with custom shoes for an enlarged foot. Cellulitis, a skin infection in the affected limb, is common because fluid drains poorly, so careful skin care and early treatment matter. When abnormal vessels reach the pelvis or bowel, bleeding into the urine or stool can occur. Clot risk rises at predictable times: after surgery, during long periods of immobility, during pregnancy and after childbirth, and with estrogen-containing birth control or hormone therapy. Planning ahead with the care team for these moments is a central part of living with KTS. Many people lead full working and family lives, and specialist centers and patient support groups can help with both medical planning and the practical and emotional side of a visible condition.

When to Seek Help

Arrange a visit with a vascular anomalies specialist if a child has a port-wine stain on a limb together with swelling, prominent veins or a size difference, or if pain, swelling or a growing leg length difference is limiting walking or activity. Raise any plans for surgery, pregnancy or hormonal birth control with the care team in advance so clot prevention can be arranged. Get seen the same day for new or worsening pain, swelling or warmth in the limb beyond its usual state, which can signal a deep vein clot, or for spreading redness, warmth and fever, which suggest cellulitis. Contact the care team right away about small amounts of blood in the urine or stool, or vaginal bleeding outside a period. Call 911 for heavy or continuing bleeding, or bleeding with dizziness or fainting. Call 911 for sudden shortness of breath, chest pain that worsens with breathing, coughing up blood, or fainting, which can mean a clot has traveled to the lungs.

Questions to Ask Your Doctor

  1. 1.Has KTS been confirmed as slow-flow, and has Parkes Weber syndrome been ruled out?
  2. 2.How extensive are the deep veins and any pelvic involvement, and do I need a D-dimer test or a blood thinner before procedures?
  3. 3.Which treatments, such as compression, sclerotherapy or surgery, would help most with my symptoms, and how many sessions might they take?
  4. 4.Would sirolimus or alpelisib be appropriate, and what would we monitor if we tried one?
  5. 5.How should we plan for pregnancy, surgery, long travel or hormonal contraception given the clotting risk?

Last reviewed • Oct 2026

Educational content, not medical advice.